A randomized in vitro evaluation of transient and permanent cardiac implantable electronic device malfunctions following direct exposure up to 10 Gy
- PMID: 32561941
- DOI: 10.1007/s00066-020-01651-7
A randomized in vitro evaluation of transient and permanent cardiac implantable electronic device malfunctions following direct exposure up to 10 Gy
Abstract
Background and purpose: High-dose 6‑MV radiotherapy may cause cardiac implantable electronic devices (CIEDs) to malfunction. To assess CIED malfunctions resulting from direct exposure up to 10 Gy, 100 pacemakers (PMs) and 40 implantable cardioverter-defibrillators (ICDs) were evaluated.
Materials and methods: CIEDs underwent baseline interrogation. In ICDs, antitachycardia therapies were disabled via the programmer while the detection windows were left enabled. A computed tomography (CT) scan was performed to build the corresponding treatment plan. CIEDs were "blinded" and randomized to receive single doses of either 2, 5, or, 10 Gy via a 6-MV linear accelerator (linac) in a water phantom. Twenty-two wireless telemetry-enabled CIEDs underwent a real-time session, and their function was recorded by the video camera in the bunker. The CIEDs were interrogated after exposure and once monthly for 6 months.
Results: During exposure, regardless of dose, 90.9% of the CIEDs recorded electromagnetic interference, with 6 ICDs (27.3%) reporting pacing inhibition and inappropriate arrhythmia detections. After exposure, a backup reset was observed in 1 PM (0.7% overall, 1% among PMs), while 7 PMs (5% overall, 7% among PMs) reported battery issues (overall immediate malfunction rate was 5.7%). During follow-up, 4 PMs (2.9% overall; 4% among PMs) and 1 ICD (0.7% overall; 2.5% among ICDs) reported abnormal battery depletion, and 1 PM (0.7% overall; 1% among PMs) reported a backup reset (overall late malfunction rate was 4.3%).
Conclusion: Apart from transient electromagnetic interference, last-generation CIEDs withstood direct 6‑MV exposure up to 10 Gy. Permanent battery or software errors occurred immediately or later only in less recent CIEDs.
Keywords: Arrhythmias; Electromagnetic interference; Implantable cardioverter-defibrillator; Pacemaker; Radiotherapy.
Similar articles
-
In-vitro investigation of cardiac implantable electronic device malfunction during and after direct photon exposure: A three-centres experience.Phys Med. 2022 Feb;94:94-101. doi: 10.1016/j.ejmp.2021.12.015. Epub 2022 Jan 7. Phys Med. 2022. PMID: 35007940
-
Effect of radiation therapy on permanent pacemaker and implantable cardioverter-defibrillator function.Heart Rhythm. 2012 Dec;9(12):1964-8. doi: 10.1016/j.hrthm.2012.08.018. Epub 2012 Aug 28. Heart Rhythm. 2012. PMID: 23102626
-
Radiotherapy and risk of implantable cardioverter-defibrillator malfunctions: experimental data from direct exposure at increasing doses.J Cardiovasc Med (Hagerstown). 2018 Apr;19(4):155-160. doi: 10.2459/JCM.0000000000000623. J Cardiovasc Med (Hagerstown). 2018. PMID: 29389805
-
Radiotherapy-induced malfunctions of cardiac implantable electronic devices: A meta-analysis.Heart Rhythm. 2023 May;20(5):689-698. doi: 10.1016/j.hrthm.2023.01.024. Epub 2023 Jan 25. Heart Rhythm. 2023. PMID: 36708909
-
A systematic review and meta-analysis on oncological radiotherapy in patients with a cardiac implantable electronic device: Prevalence and predictors of device malfunction in 3121 patients.Eur J Clin Invest. 2023 Jan;53(1):e13862. doi: 10.1111/eci.13862. Epub 2022 Sep 7. Eur J Clin Invest. 2023. PMID: 36004486 Free PMC article.
Cited by
-
Increase in right ventricular lead pacing threshold following stereotactic ablative therapy for ventricular tachycardia.HeartRhythm Case Rep. 2023 May 26;9(8):555-559. doi: 10.1016/j.hrcr.2023.05.011. eCollection 2023 Aug. HeartRhythm Case Rep. 2023. PMID: 37614389 Free PMC article. No abstract available.
-
Risk of cardiac implantable device malfunction in cancer patients receiving proton therapy: an overview.Front Oncol. 2023 Jul 4;13:1181450. doi: 10.3389/fonc.2023.1181450. eCollection 2023. Front Oncol. 2023. PMID: 37469405 Free PMC article. Review.
-
Implantable cardiac pacemaker failure by cumulative dose effects of flattening filter free beams.J Radiat Res. 2021 Jul 10;62(4):735-739. doi: 10.1093/jrr/rrab041. J Radiat Res. 2021. PMID: 34036327 Free PMC article.
References
-
- Mond HG, Proclemer A (2011) The 11th world survey of cardiac pacing and implantable cardioverter-defibrillators: calendar year 2009—a world society of arrhythmia’s project. Pacing Clin Electrophysiol 34:1013–1027. https://doi.org/10.1111/j.1540-8159.2011.03150.x - DOI - PubMed
-
- Køber L, Thune JJ, Nielsen CJ, Haarbo J, Videbæk L, Korup E, Jensen G, Hildebrandt P, Steffensen FH, Bruun NE, Eiskjær H, Brandes A, Thøgersen AM, Gustafsson F, Egstrup K, Videbæk R, Hassager C, Svendsen JH, Høfsten DE, Torp-Pedersen C, Pehrson S, DANISH Investigators (2016) Defibrillator implantation in patients with nonischemic systolic heart failure. N Engl J Med 375(13):1221–1230. https://doi.org/10.1056/NEJMoa1608029 - DOI - PubMed
-
- Jukema WJ, Timal RJ, Rotmans JI, Hensen LCR, Buiten MS, de Bie MK, Putter H, Zwinderman AH, van Erven L, Krol-van Straaten MJ, Hommes N, Gabreëls B, van Dorp W, van Dam B, Herzog CA, Schalij MJ, Rabelink TJ, ICD2 Trial Investigators (2019) Prophylactic of Implantable cardioverter-defibrillators in the prevention of sudden cardiac death in dialysis patients. Circulation 139(23):2628–2638. https://doi.org/10.1161/circulationaha.119.039818 - DOI - PubMed
-
- Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90. https://doi.org/10.3322/caac.20107 - DOI - PubMed
-
- Passman R, Kadish A (2007) Sudden death prevention with implantable devices. Circulation 116:561–571. https://doi.org/10.1161/circulationaha.106.655704 - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical